Sonnet Biotherapeutics Holdings Inc (SONN)

02:06 AM

Sonnet Biotherapeutics Faces Earnings Volatility with New HYPE Treasury Strategy and Accounting Standards - TipRanks

02:06 AM

Aug 14, 2025

Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 14, 2025

Aug 12, 2025

Why Sonnet BioTherapeutics Holdings Inc. stock attracts strong analyst attentionStrong MACD Crossover Alerts - thegnnews.com

Aug 12, 2025

Aug 11, 2025

Pilot Killed In NJ Crash Was CEO Of Cancer-Focused Biotech Company - MSN

Aug 11, 2025

Aug 11, 2025

Sonnet Releases Virtual Investor 'What This Means' Segment - The Manila Times

Aug 11, 2025

Aug 11, 2025

Sonnet Releases Virtual Investor "What This Means" Segment - GlobeNewswire

Aug 11, 2025

Aug 11, 2025

Breakthrough: Sonnet's Ovarian Cancer Drug Achieves 67% Response Rate, Trial Expands with Higher Dose - Stock Titan

Aug 11, 2025

Aug 11, 2025

Why Did Sonnet BioTherapeutics Holdings Soar 11.49%? - AInvest

Aug 11, 2025

Aug 11, 2025

Sonnet BioTherapeutics Holdings Inc. Added to High Probability Setup ListStock Portfolio Allocation Guidance for Volatile Markets - beatles.ru

Aug 11, 2025

Aug 09, 2025

Short Interest Drops in Sonnet BioTherapeutics Holdings Inc. After RallyCommunity Strategy With High Win Rate Backtested - beatles.ru

Aug 09, 2025

Aug 08, 2025

Sonnet Biotherapeutics Holdings Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView

Aug 08, 2025

Aug 04, 2025

This Cancer Biotech Company Is Making a Big Bet on the HYPE Crypto. Should You Buy Its Stock Here? - Yahoo Finance

Aug 04, 2025

Aug 04, 2025

Sonnet BioTherapeutics Expands Clinical Study of SON-1010 in Combination with Atezolizumab for Advanced Platinum-Resistant Ovarian Cancer - Quiver Quantitative

Aug 04, 2025

Aug 04, 2025

Sonnet BioTherapeutics Expands Clinical Evaluation of - GlobeNewswire

Aug 04, 2025

Aug 04, 2025

Cancer Drug Shows 66% Response Rate in Ovarian Cancer Trial: Sonnet BioTherapeutics Advances to Higher Dose - Stock Titan

Aug 04, 2025

Aug 04, 2025

Sonnet BioTherapeutics Makes Big Bet on HYPE Crypto Amid Growing Trend in Crypto Treasury Companies. - AInvest

Aug 04, 2025

Aug 04, 2025

Live Chart Scan Detects Wedge Pattern in Sonnet BioTherapeutics Holdings Inc.Swing Trade Entry With Volume Triggers Released - beatles.ru

Aug 04, 2025

Aug 03, 2025

Is Sonnet BioTherapeutics Holdings Inc. stock overvalued or undervaluedRecord-breaking capital gains - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the dividend policy of Sonnet BioTherapeutics Holdings Inc. stockBuild wealth faster with disciplined trading - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Why is Sonnet BioTherapeutics Holdings Inc. stock attracting strong analyst attentionCapitalize on proven investment strategies - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How strong is Sonnet BioTherapeutics Holdings Inc. company’s balance sheetFree Daily Trading Room Entry - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What analysts say about Sonnet BioTherapeutics Holdings Inc. stockIdentify undervalued stocks poised to rally - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are the latest earnings results for Sonnet BioTherapeutics Holdings Inc.Fastest return on investment - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What institutional investors are buying Sonnet BioTherapeutics Holdings Inc. stockExpert guidance for superior capital growth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the risk reward ratio of investing in Sonnet BioTherapeutics Holdings Inc. stockTransform your portfolio with high-yield stocks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What drives Sonnet BioTherapeutics Holdings Inc. stock priceStay ahead with daily market updates - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What catalysts could drive Sonnet BioTherapeutics Holdings Inc. stock higher in 2025Dynamic profit expansion - Jammu Links News

Aug 03, 2025

Aug 02, 2025

Is it the right time to buy Sonnet BioTherapeutics Holdings Inc. stockHigh-velocity gains - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Sonnet BioTherapeutics Appoints Interim CEO Raghu Rao - The Globe and Mail

Aug 02, 2025

Aug 01, 2025

Sonnet BioTherapeutics enters employment agreement with interim CEO Raghu Rao - Investing.com Australia

Aug 01, 2025

Jul 31, 2025

Is this a good reentry point in Sonnet BioTherapeutics Holdings Inc.Earnings Play Trade Plan With Alerts Shared - metal.it

Jul 31, 2025

Jul 31, 2025

Is Sonnet BioTherapeutics Holdings Inc. a growth stock or a value stockBest Dividend Insights For Fast Growth - Jammu Links News

Jul 31, 2025

Jul 30, 2025

Real time social sentiment graph for Sonnet BioTherapeutics Holdings Inc.Daily Smart Money Movement Monitor Activated - metal.it

Jul 30, 2025

Jul 29, 2025

Published on: 2025-07-30 03:59:14 - metal.it

Jul 29, 2025

Jul 29, 2025

Published on: 2025-07-29 23:38:09 - metal.it

Jul 29, 2025

Jul 29, 2025

Published on: 2025-07-29 20:04:07 - metal.it

Jul 29, 2025

Jul 29, 2025

Pattern Scan Adds Sonnet BioTherapeutics Holdings Inc. to WatchlistWealth Building Stock Market Ideas Based on Momentum - beatles.ru

Jul 29, 2025

Jul 28, 2025

Analyzing net buyer seller activity in Sonnet BioTherapeutics Holdings Inc.Insider Strategy for High Conviction Picks - Newser

Jul 28, 2025

Jul 27, 2025

Sonnet BioTherapeutics Holdings Inc. Company Revenue and Profit Trends: A Deep DiveWeekly Double Return List - metal.it

Jul 27, 2025